Fintel reports that on September 5, 2025, Clear Street initiated coverage of Crescent Capital BDC (NasdaqGM:CCAP) with a Buy recommendation.

Analyst Price Forecast Suggests 9.52% Upside

As of September 3, 2025, the average one-year price target for Crescent Capital BDC is $17.42/share. The forecasts range from a low of $15.15 to a high of $21.00. The average price target represents an increase of 9.52% from its latest reported closing price of $15.91 / share.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Crescent Capital BDC is 216MM, an increase of 17.91%. The projected annual non-GAAP EPS is 1.89.

What is the Fund Sentiment?

There are 104 funds or institutions reporting positions in Crescent Capital BDC. This is an increase of 9 owner(s) or 9.47% in the last quarter. Average portfolio weight of all funds dedicated to CCAP is 0.25%, an increase of 45.15%. Total shares owned by institutions increased in the last three months by 34.75% to 23,715K shares. The put/call ratio of CCAP is 0.46, indicating a bullish outlook.

What are Other Shareholders Doing?

Texas County & District Retirement System holds 5,002K shares. No change in the last quarter.

Fidelity National Financial holds 4,205K shares. No change in the last quarter.

Blackstone Group holds 4,205K shares. In its prior filing, the firm reported owning 3,796K shares , representing an increase of 9.73%. The firm decreased its portfolio allocation in CCAP by 6.20% over the last quarter.

Sun Life Financial holds 2,226K shares. No change in the last quarter.

Ares Management holds 516K shares. In its prior filing, the firm reported owning 470K shares , representing an increase of 9.07%. The firm decreased its portfolio allocation in CCAP by 24.52% over the last quarter.